New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
08:12 EDTHSP, DANOYHospira to obtain financial benefits from possible Danone deal, says Wells Fargo
After multiple media sources reported that Hospira (HSP) is in talks to buy Danone's (DANOY) medical nutrition business in a potential tax inversion deal, Wells Fargo estimates that the deal could be 9%-12% accretive to Hospira's EPS in 2015-2017 if it's an all-stock deal and 20%-22% accretive if it's a 50%/50% cash and stock deal. The firm The firm estimates that Hospira's tax bill would be cut to 21% in 2015 and 19% afterwards, from its current forecast of 24%-26% during those years. The firm thinks the strategic rationale for the deal from Hospira's perspective, however, is less clear. It keeps a Market Perform rating on the stock.
News For HSP;DANOY From The Last 14 Days
Check below for free stories on HSP;DANOY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 16, 2014
07:49 EDTDANOYBofA/Merrill to hold a conference
Subscribe for More Information
September 9, 2014
12:15 EDTHSPHospira expects 2015 to be a turnaround year for pump business
Subscribe for More Information
11:57 EDTHSPHospira says it has appealed court's adverse decision relating to Precedex
The argument for appeal has been set for October 27. Comments taken from Morgan Stanley Global Healthcare Conference.
September 8, 2014
12:40 EDTHSPPar Pharmaceutical resumes shipment of generic Precedex Injection
Subscribe for More Information
08:33 EDTHSPHospira confirms FY14 EPS view $2.30-$2.50, consensus $2.41
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use